Clinical and immunological follow-up of very long-term kidney transplant recipients treated with calcineurin inhibitors indicates dual phenotypes
Open Access
- 30 October 2020
- journal article
- research article
- Published by Elsevier BV in Kidney International
- Vol. 99 (6), 1418-1429
- https://doi.org/10.1016/j.kint.2020.09.036
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- Risk Factors for Early Graft Failure and Death After Kidney Transplantation in Recipients Older Than 70 YearsKidney International Reports, 2019
- Health-related quality of life compared between kidney transplantation and nocturnal hemodialysisPLOS ONE, 2018
- Tolerance Induction in Kidney TransplantationAmerican Journal of Transplantation, 2018
- Updated follow-up of a tolerance protocol in HLA-identical renal transplant pairs given donor hematopoietic stem cellsHuman Immunology, 2018
- Tolerance after liver transplantation: Where are we?Liver Transplantation, 2017
- Can immunosuppression be stopped after liver transplantation?The Lancet Gastroenterology & Hepatology, 2017
- Finding the safe place between the hammer and the anvil: sounding the depth of therapeutic immunosuppressionKidney International, 2015
- Risk Stratification for Rejection and Infection after Kidney TransplantationClinical Journal of the American Society of Nephrology, 2015
- Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipientsJournal of Hepatology, 2013
- Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and NonadherenceAmerican Journal of Transplantation, 2011